Tap here to turn on desktop notifications to get the news sent straight to you.
Drug Companies Are Slowly Starting To Care More About Poor People
The industry often doesn't invest in medications and vaccines for people who can’t afford to pay high prices.
Damien Guerchois / Reuters
Is Antimicrobial Resistance On Your Radar Yet?
Director General of United Nations Office at Geneva
Tiny Quantum Dots May Spell Doom For Deadly Superbug Infections
Scientists say the light-activated nanoparticles wipe out infectious bacteria without harming healthy cells
iLexx via Getty Images
Most Countries Have No National Plan To Tackle Growing 'Superbug' Threat
Where Do the Candidates Stand on Research to Improve Health?
President and CEO, Research!America
No Z-Pak for You!*
Ranit Mishori, M.D., MHS
Physician; Writer; Professor of Family Medicine, Georgetown Un...
Don't get me wrong. Antibiotics are great. But our use of antibiotics -- often overuse, misuse or unnecessary use -- has contributed to antibiotic resistance. It is a global public health emergency.
To Fight Superbugs, Fight Poverty
Lecturer at Harvard Medical School. Writing a book on empathy ...
In addition to alleviating the burden of copayments for the poorest patients, what might make a difference in the fight against antimicrobial resistance in low-income countries is the same as what might make a difference in the fight against Zika or Ebola.
Do you have info to share with HuffPost reporters?
Culture & Arts
TV & Film
Style & Beauty
Food & Drink
Home & Living
Impact: Project Zero
Impact: This New World
Listen to America
FROM OUR PARTNERS
Sleep & Wellness
What's Working: Purpose + Profit
The Power of Humanity
Expert analysis and commentary to make sense of today's biggest stories.
Sign up here to have the best stories delivered straight to your inbox.
First-person essays, features, interviews and Q&As about life today.
Get breaking news alerts
Download our app
Go to mobile site